Stocks
Aspira Women's Health Financial Statements (AWH) |
||||||||||
| Aspira Women's Healthsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.03.2022 | 30.03.2023 | 26.10.2023 | 31.12.2023 | 01.04.2024 | 13.08.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 6.81 | 8.18 | 8.18 | 9.15 | 9.15 | 9.13 | |||
| Operating Income, bln rub | -32.6 | -32.8 | -32.8 | -18.9 | -18.9 | -17.6 | ||||
| EBITDA, bln rub | ? | -32.3 | -38.2 | -30.9 | -18.9 | -16.5 | -17.5 | |||
| Net profit, bln rub | ? | -31.7 | -21.6 | -21.6 | -16.7 | -16.7 | -14.8 | |||
| OCF, bln rub | ? | -27.4 | -32.2 | -32.2 | -15.9 | -11.6 | ||||
| CAPEX, bln rub | ? | 0.184 | 0.232 | 0.232 | 0.024 | 0.047 | ||||
| FCF, bln rub | ? | -27.6 | -32.4 | -32.4 | -15.9 | -11.7 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 35.7 | 37.1 | 37.1 | 24.1 | 24.1 | 22.9 | ||||
| Cost of production, bln rub | 3.75 | 3.87 | 3.87 | 3.89 | 3.89 | 3.85 | ||||
| R&D, bln rub | 5.31 | 5.95 | 5.95 | 4.04 | 4.04 | 3.89 | ||||
| Interest expenses, bln rub | 0.048 | 0.017 | 0.017 | 0.000 | 0.000 | 0.059 | ||||
| Assets, bln rub | 41.1 | 17.4 | 17.4 | 6.26 | 6.26 | 3.96 | ||||
| Net Assets, bln rub | ? | 30.2 | 6.73 | 6.73 | -2.37 | -2.37 | -3.71 | |||
| Debt, bln rub | 4.11 | 3.83 | 3.83 | 2.85 | 2.85 | 2.36 | ||||
| Cash, bln rub | 37.2 | 13.3 | 13.3 | 2.60 | 2.60 | 0.962 | ||||
| Net debt, bln rub | -33.1 | -9.48 | -9.48 | 0.26 | 0.26 | 1.40 | ||||
| Ordinary share price, rub | 26.6 | 4.95 | 4.95 | 4.08 | 4.08 | 4.80 | ||||
| Number of ordinary shares, mln | 7.41 | 0.518 | 0.518 | 9.23 | 9.23 | 12.5 | ||||
| Market cap, bln rub | 197 | 3 | 3 | 38 | 38 | 60 | ||||
| EV, bln rub | ? | 164 | -7 | -7 | 38 | 38 | 61 | |||
| Book value, bln rub | 30 | 7 | 7 | -2 | -2 | -4 | ||||
| EPS, rub | ? | -4.28 | -41.7 | -41.7 | -1.81 | -1.81 | -1.18 | |||
| FCF/share, rub | -3.72 | -62.6 | -62.6 | 0.00 | -1.72 | -0.93 | ||||
| BV/share, rub | 4.07 | 13.0 | 13.0 | -0.26 | -0.26 | -0.30 | ||||
| EBITDA margin, % | ? | -474.1% | -467.2% | -377.2% | -205.9% | -180.2% | -192.1% | |||
| Net margin, % | ? | -465.5% | -263.6% | -263.6% | -182.3% | -182.3% | -161.9% | |||
| FCF yield, % | ? | -14.0% | -1 264% | -1 264% | 0.00% | -42.3% | -19.4% | |||
| ROE, % | ? | -105.1% | -320.5% | -320.5% | 705.7% | 705.7% | 398.4% | |||
| ROA, % | ? | -77.2% | -124.2% | -124.2% | -266.5% | -266.5% | -373.1% | |||
| P/E | ? | -6.21 | -0.12 | -0.12 | -2.26 | -2.26 | -4.07 | |||
| P/FCF | -7.14 | -0.08 | -0.08 | -2.37 | -5.15 | |||||
| P/S | ? | 28.9 | 0.31 | 0.31 | 4.12 | 4.12 | 6.58 | |||
| P/BV | ? | 6.52 | 0.38 | 0.38 | -15.9 | -15.9 | -16.2 | |||
| EV/EBITDA | ? | -5.07 | 0.18 | 0.22 | -2.01 | -2.30 | -3.51 | |||
| Debt/EBITDA | 1.02 | 0.25 | 0.31 | -0.01 | -0.02 | -0.08 | ||||
| R&D/CAPEX, % | 2 888% | 2 566% | 2 566% | 16 813% | 8 270% | |||||
| CAPEX/Revenue, % | 2.70% | 2.83% | 2.83% | 0.00% | 0.26% | 0.51% | ||||
| Aspira Women's Health shareholders | ||||||||||
